Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lívia Budai is active.

Publication


Featured researches published by Lívia Budai.


Scientia Pharmaceutica | 2013

Liposomes for Topical Use: A Physico-Chemical Comparison of Vesicles Prepared from Egg or Soy Lecithin

Lívia Budai; Nóra Kaszás; Pál Gróf; Katalin Lenti; Katayoon Maghami; István Antal; Imre Klebovich; Ilona Petrikovics; Marianna Budai

Developments in nanotechnology and in the formulation of liposomal systems provide the opportunity for cosmetic dermatology to design novel delivery systems. Determination of their physico-chemical parameters has importance when developing a nano-delivery system. The present study highlights some technological aspects/characteristics of liposomes formulated from egg or soy lecithins for topical use. Alterations in the pH, viscosity, surface tension, and microscopic/macroscopic appearance of these vesicular systems were investigated. The chemical composition of the two types of lecithin was checked by mass spectrometry. Caffeine, as a model molecule, was encapsulated into multilamellar vesicles prepared from the two types of lecithin: then zeta potential, membrane fluidity, and encapsulation efficiency were compared. According to our observations, samples prepared from the two lecithins altered the pH in opposite directions: egg lecithin increased it while soy lecithin decreased it with increased lipid concentration. Our EPR spectroscopic results showed that the binding of caffeine did not change the membrane fluidity in the temperature range of possible topical use (measured between 2 and 50 °C). Combining our results on encapsulation efficiency for caffeine (about 30% for both lecithins) with those on membrane fluidity data, we concluded that the interaction of caffeine with the liposomal membrane does not change the rotational motion of the lipid molecules close to the head group region. In conclusion, topical use of egg lecithin for liposomal formulations can be preferred if there are no differences in the physico-chemical properties due to the encapsulated drugs, because the physiological effects of egg lecithin vesicles on skin are significantly better than that of soy lecithin liposomes.


Toxicology and Industrial Health | 2012

Nanoencapsulated and microencapsulated enzymes in drug antidotal therapy.

Mária Szilasi; Marianna Budai; Lívia Budai; Ilona Petrikovics

A catalytic bioscavenger for the therapeutic and prophylactic defense against recognized chemical threat agents has been a long-standing objective of civilian and military research. Among the toxic agents, organophosphate molecules and cyanide have been widely studied. In order to overcome the limitations of traditional antidotal therapies, isolated, purified, recombinant enzymes with bacterial origin possessing fast catalytic activity were used in in vitro and in vivo experiments. However, the fast degradation, excretion and adverse immunologic reaction against enzymes limit their in vivo use. Development of biodegradable, nontoxic carrier systems, microparticles, and nanoparticles—offering advantageous pharmacokinetic parameters was suggested. Present work deals with the perspectives of carrier systems, such as resealed and annealed erythrocytes and sterically stabilized liposomes. Dendritic polymers and polymer-conjugated enzymes, being in the focus of extensive research efforts nowadays, are also discussed.


Journal of Physics: Conference Series | 2015

The influence of selected excipients on the rheological behaviour of chitosan based ocular pharmaceutical systems

Lívia Budai; E Szabadi; Mária Hajdú; Marianna Budai; Imre Klebovich; István Antal

Aims: Chitosan, a modified natural carbohydrate polymer, has received great attention in diverse scientific fields including pharmaceutical and biomedical research areas. Besides its low toxicity, mucoadhesiveness and biodegradability its special favourable rheological feature makes it a unique gelling agent for the design of ocular systems. Chitosan based (2.0 w/v %) ocular systems containing selected excipients were formulated in order to investigate the rheological influence of applied auxiliary materials. Rotational and oscillatory rheological properties of propylene glycol (1.0-20.0 w/v %), glycerin (1.0-5.0 w/v %) and castor oil (1.0-5.0 w/v %) containing chitosan gels were evaluated. The rheological behaviour of formulated ocular gels were compared before and after steam sterilization.Methods: Rotational and oscillatory rheological measurements were carried out with Kinexus Pro Rheometer. Comparison of flow curves and oscillatory frequency sweep measurements in the linear viscoelastic region made possible the evaluation of rheological effect of selected excipients.Results: In the applied concentration range the effect of propylene glycol among the selected excipients presents the most significant impact on rheology of chitosan formulations. Steam sterilization results in reduced viscosity in most of chitosan gels. However, the presence of polyols appears to prevent the degradation of chitosan after steam sterilization.


International Journal of Pharmaceutics | 2007

Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations.

Lívia Budai; Mária Hajdú; Marianna Budai; Pál Gróf; Szabolcs Béni; Béla Noszál; Imre Klebovich; István Antal


Journal of Cosmetic Science | 2012

Natural oils and waxes: studies on stick bases.

Lívia Budai; István Antal; Imre Klebovich; Marianna Budai


Drug discoveries and therapeutics | 2009

Liposomal oxytetracycline and doxycycline: studies on enhancement of encapsulation efficiency.

Marianna Budai; Patricia Chapela; Lívia Budai; Melinda E. Wales; Ilona Petrikovics; Andreas Zimmer; Pál Gróf; Imre Klebovich


Current Pharmaceutical Analysis | 2014

Application of droplet size analysis for the determination of the required HLB of lemon oil in O/W emulsion

Noémi Anna Niczinger; N. Kallai-Szabo; J. Dredán; Lívia Budai; Mária Hajdú; István Antal


Research & Reviews: Journal of Pharmaceutics and Nanotechnology | 2015

Liposomal Encapsulation of Photoprotector Molecules

Reny J Roy; Lívia Budai; Loránd Kiss; Magdolna E Szilasi; Ilona Petrikovics; Marianna Budai


Acta pharmaceutica Hungarica | 2011

A HLB-érték jelentosége a gyó gyszertechnológiában

Noémi Anna Niczinger; Mária Hajdú; Lívia Budai; J. Dredán; István Antal


Acta pharmaceutica Hungarica | 2008

Methods to increase the encapsulation efficiency for liposomal drugs

Nóra Kaszás; Marianna Budai; Lívia Budai; Pál Gróf; Andreas Zimmer; Imre Klebovich

Collaboration


Dive into the Lívia Budai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ilona Petrikovics

Sam Houston State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge